Global Indemnity Group, LLC - Class A Common Stock (GBLI)
35.00
0.00 (0.00%)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
GBLI stock results show that Global Indemnity Group beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQSGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via Benzinga · March 13, 2024
![](https://cdn.benzinga.com/files/images/story/2023/dividend_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 18, 2023